SCHEMBL3388679

SCHEMBL3388679

N#CC(=C1CCNCC1)c1ccno1

nearest known ligand 0.35

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CHRNA4 P43681 2/20 0.35
CHRNB2 P17787 1/20 0.35
CHRNB4 P30926 1/20 0.35
CHRNA3 P32297 1/20 0.35
CHRNA7 P36544 1/20 0.35
PRKACA P17612 1/20 0.34
PRKACG P22612 1/20 0.34
PRKACB P22694 1/20 0.34
GPR6 P46095 1/20 0.32
MEN1 O00255 1/20 0.31
NPC1 O15118 1/20 0.31
ALDH1A1 P00352 1/20 0.31
GAA P10253 1/20 0.31
RAB9A P51151 1/20 0.31
KMT2A Q03164 1/20 0.31
MAPK1 P28482 1/20 0.30
CASP1 P29466 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL940026 0.76 CHRNA4 (0.37) CHRNA4CHRNB2CHRNB4CHRNA3CHRNA7
SCHEMBL10268122 0.72 CHRNB2 (0.38) CHRNA4CHRNB2CHRNB4CHRNA3CHRNA7
SCHEMBL12829020 0.69 OPRD1 (0.43) ALDH1A1
SCHEMBL2080353 0.69 OPRD1 (0.44) MEN1NPC1ALDH1A1GAARAB9A
SCHEMBL1472474 0.68 CHRNB2 (0.41) CHRNA4CHRNB2MEN1NPC1ALDH1A1
SCHEMBL12829021 0.68 PROKR1 (0.46)
SCHEMBL9853163 0.68 POLB (0.47) CHRNA4CHRNB2CHRNB4CHRNA3CHRNA7
Hydrochloric Acid SCHEMBL2689542 0.68 OPRD1 (0.43) MEN1NPC1ALDH1A1GAARAB9A
SCHEMBL12828714 0.67 OPRM1 (0.43) MEN1NPC1ALDH1A1GAARAB9A
Hydrochloric Acid SCHEMBL16321264 0.67 PROKR1 (0.46)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2212332-A1 SUBSTITUTED TRICYCLIC COMPOUNDS AND METHODS OF USE THEREOF Bayer Schering Pharma Aktiengesellschaft (DE) 2010-08-04 EP disclosed
WO-2009033581-A1 SUBSTITUTED TRICYCLIC COMPOUNDS AND METHODS OF USE THEREOF BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2009-03-19 WO disclosed